Results 91 to 100 of about 730 (126)

Evaluación de polimorfismos en los genes ABCB1 y ABCC2 en pacientes con epilepsia resistente a fármacos del policlínico de neurología del Hospital Carlos Van Buren

open access: yes, 2017
La Epilepsia es un trastorno neurológico frecuente que afecta entre el 1 y 2% de la población general. Del total de los pacientes que son diagnosticados con epilepsia, aproximadamente el 25% de ellos no logran control de sus crisis pese al tratamiento ...
Riquelme Alcázar, Julio
core  

[Most frequently used drugs in suicide attempts and their organic complications in a tertiary care hospital]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Saucedo-Montero HA   +5 more
europepmc   +1 more source

[Recommendations for the use of neurophysiological techniques in the diagnosis of brain death from the Clinical Neurophysiology Society of the Communities of Valencia and Murcia]. [PDF]

open access: yesRev Neurol, 2022
Arciniegas-Villanueva AV   +13 more
europepmc   +1 more source

[The added value of Professional Pharmaceutical Assistance Services. A case of pharmaceutical care]. [PDF]

open access: yesFarm Comunitarios, 2023
Abdala Kuri S   +3 more
europepmc   +1 more source

[Posterior reversible encephalopathy syndrome in critical COVID-19 patients: Report of 2 cases]. [PDF]

open access: yesRev Esp Anestesiol Reanim, 2023
Tortajada Soler JJ   +5 more
europepmc   +1 more source

Fármacos antiepilépticos

open access: yes, 2011
Antonio Gil-Nagel Rein
core   +1 more source

[The Usefulness of Neuromodulators in Clinical Practice: The Gastroenterologist's Viewpoint]. [PDF]

open access: yesActa Gastroenterol Latinoam
García-Zermeño KR   +3 more
europepmc   +1 more source

[Pharmaceutical interventions in the new medicine service].

open access: yesFarm Comunitarios
Borja Ripoll S   +2 more
europepmc   +2 more sources

[Study of anticholinergic burden in chronic treatments of outpatients in the Community Pharmacy]. [PDF]

open access: yesFarm Comunitarios
Zaragoza Noguera R   +2 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy